Top Markets
Coin of the day
Dr. Miele Cosmed Group S.A. Dr. Miele Cosmed Group S.A.

Dr. Miele Cosmed Group S.A.

DMG
Classement en actions #24835
Dr. Miele Cosmed Group S.A., founded in 1990 and headquartered in Radom,... Dr. Miele Cosmed Group S.A., founded in 1990 and headquartered in Radom, Poland, is actively involved in the global production and distribution of a diverse array of chemical and cosmetic products. Their extensive portfolio includes personal hygiene items such as shower gels, liquid soaps, and sanitizing gels and sprays, alongside a dedicated range for children encompassing washing and care cosmetics, wet wipes, and laundry detergents. The company also manufactures household cleaning essentials, offering toilet cleaners, toilet blocks, drain openers (in granule and gel form), washing liquids, fabric softening concentrates, and specific agents for kitchen and bathroom cleaning, as well as hand and surface disinfectants. These offerings are prominently marketed under brands like Bobini, Apart, Biophen, Mole, Sofin, Izo, and Izozid. The company officially adopted its current name, Dr. Miele Cosmed Group S.A., in March 2024, having previously operated as Global Cosmed S.A.
Prix de l'action
$0.65312925
Capitalisation boursière
$56.02M
Changement (1 jour)
0.00%
Changement (1 an)
-34.96%
Pays
PL
Échange Dr. Miele Cosmed Group S.A. (DMG)
Bénéfices pour Dr. Miele Cosmed Group S.A. (DMG)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Dr. Miele Cosmed Group S.A., les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Dr. Miele Cosmed Group S.A. de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$20.38B -
US
$9.83B -
FR
$2.94B -
US
$1.55B -
IN
- -
DE